We want to bring hope to patients, families and their clinical practitioners by providing a solution that can help you live a full and happy life after experiencing a stroke.

Often stroke patients may feel that their mobility condition is just ‘how it is’, rather than seeing the possibility for a substantial or full recovery of mobility and independence.

Moterum Technologies focuses on the needs of mobility-challenged people due to disease, accident, or condition. We design, develop, and sell high impact products in the field of mobility and rehabilitation for those who have survived a stroke, traumatic brain injury, or spinal injury.

How We Serve

By providing enabling technology that will help stroke patients relearn how to walk safely and symmetrically, Moterum Technologies strives to change the lives of the 60 million plus stroke survivors, and millions of other neural trauma survivors around the world who struggle to walk on a daily basis.

The Moterum iStride Solution™ , covered by dozens of patent applications and issued patents, changes the gait of its user to re-pattern the user’s brain so they relearn how to walk, while monitoring, assessing, and engaging through a digital therapeutic platform. The device has successfully been used in clinical trials to help people walk faster, reduce fall risk, and improve balance. It is commercially available with a prescription

Partnerships

Our well-educated team maintains a diverse background dedicated to helping those in need by solving real-life problems. A list of our current products and descriptions is located here.

We design, develop, and test high impact products in the field of mobility and rehabilitation.

Our projects arise from recognizing the unsolved problems of mobility challenged people. We solve these problems with new technology that we develop to help you and your family live full, mobility independent lives. Our company is focused on sourcing, designing, engineering, manufacturing and selling the highest quality products to significantly impact people through addressing the problems of stroke rehabilitation and other chronic neural disorders.

Currently we have developed a next generation Moterum iStride Solution™, which has completed two clinical trials. We are also beginning clinical trials at Roger C. Peace Rehabilitation Hospital and the Greenville Health System in Greenville, SC with our lower limb stretching device for spasticity.

Leadership Team

DAVID HUIZENGA

DAVID HUIZENGA

Founder and CEO

Read More

David E. Huizenga is the founder and CEO of Moterum Technologies Inc., a medical device company in stroke rehabilitation. He is an expert in translating groundbreaking science into realistic commercial opportunities. Over the last 5 years, he has focused his efforts on the unique needs of the neural rehabilitation patient. Previously, David was CEO and cofounder of Tao Life Sciences LLC, an early stage life sciences technology development and investment company, which successfully monetized over half of its portfolio. David has been on the founding team of numerous life science companies, and has involvement in successful acquisitions and exits. Mr. Huizenga obtained his Ph.D. from Harvard, in the laboratory of Jack Szostak, Nobel Laureate in Medicine, and his Law Degree from Emory University Law School, where he was a Woodruff Fellow. Mr. Huizenga serves on numerous corporate and non-profit boards.

MANOJ AGARWALA

MANOJ AGARWALA

President

Read More

Manoj Agarwala is a serial entrepreneur. He successfully started and grew two technology companies – hCentive and GlobalLogic which grew to over 5,000 employees and expanded to over 6 countries. He was President and Chief Operating Officer for hCentive from 2009 to 2016. At hCentive Manoj oversaw the company’s Operations, Finance, Legal, R&D, Professional Services and Marketing.

DOUGLAS GOLDSTEIN

DOUGLAS GOLDSTEIN

Chief Growth Officer

Read More

As a leader, Doug has developed innovative solutions using technology, big data, artificial intelligence and human ingenuity for healthcare leaders. Recently as the Innovation Officer for the Inova Center for Personalized Health he generated millions of dollars in translational research funding from global life sciences and medical devices companies. As the CEO of iConecto, Inc., Doug built mobile health and rehabilitation solutions for health systems. As the founder and CEO of Health Online, Inc. he developed the first syndicated health web portal service and acquired the first social network in health, as he grew revenues to a run rate of $10M. As an author and speaker, he has published 11 books and delivered 250 keynotes for 10,000 health executives.
TIMOTHY OVINGTON

TIMOTHY OVINGTON

Chief Revenue Officer

Read More

Seasoned and experienced sales and marketing executive with demonstrated success in building and leading teams. Tim has worked with multiple surgical specialties including: General, Ob/Gyn, Interventional Cardiology, Cardio-thoracic, Ortho, Neuro, and ENT. Extremely adept at launching innovative technologies into highly competitive markets, and highly skilled at formulating and executing strategic plans driving outstanding revenue and profitability results. Recognized by both employers and peers for the strong results I and my teams have achieved. Now focusing my talents in the Neuro-Health field with Moterum Technologies in helping stroke survivors and their caregivers regain their independence.
JUANITA NIDHINDRA

JUANITA NIDHINDRA

SVP Global Operations

Read More

A zestful individual with 20+ years of IT and R&D experience. Juanita is responsible for global operations for Moterum, Inc., building a high-performance development team to deliver the Moterum vision. Prior to Moterum, Juanita was the head of Global Operations for 9zest, Program Office Head for GlobalLogic India and delivered several cross-functional projects and global programs for the CXOs’ offices.

LAUREN RASHFORD

LAUREN RASHFORD

Director of Clinical Operations

Read More

Lauren is the Director of Clinical Operations and Customer Development at Moterum Technologies. She holds a doctorate in physical therapy and brings substantial experience in the neuro-rehabilitation world, including clinical management and business development roles. With her strong background in both clinical and commercial rehabilitation she offers expertise in clinical strategy and integration. Lauren has been responsible for clinical operations, building and leveraging clinic partnerships, and delivering current protocols/education to other clinic staff. Additionally, Lauren will continue to cultivate, build and maintain relationships that help foster the clinical integration process.

SHIV MOHAN SINGH

SHIV MOHAN SINGH

VP Software Engineering

Read More

A product development enthusiast having 21+ years of experience in delivering enterprise grade products. Bachelor’s degree in Engineering from Indian Institute of Technology, Roorkee and master’s from Birla Institute of Technology and Science, Pilani. He has held a number of Engineering leadership roles at HCL, Adobe, GlobalLogic etc.

TIMOTHY  HESS

TIMOTHY HESS

Director of Engineering

Read More

Tim is the Director of Engineering and Product Development at Moterum Technologies. He brings experience along the whole spectrum of product development from concept generation to manufacturing in a variety of industries, including automotive, powersports, consumer goods, and medical devices. Tim holds Bachelors and Masters degrees in Mechanical Engineering from Clemson University. While in graduate school, as a member of the Clemson Engineering Design and Applications Research (CEDAR) Lab at Clemson University, Tim studied the value of prototyping through different stages of the product design process. After graduation and spending several years in industry, Tim returned to Clemson University and earned an MBA with a concentration in Innovation and Entrepreneurship. Since then, he has been working with entrepreneurs and startup companies to develop new products and technologies.

DEEPAK NAIN

DEEPAK NAIN

Head of Therapy Protocol

Read More

Deepak Kumar Nain is the Head of Therapy Protocols at Moterum Technologies. He has worked extensively with patients with Stroke, neurological disorders, and balance and vestibular disorders. He has more than 12 years of clinical experience focusing on the development of interventions promoting neuroplasticity and the use of adjuvant strategies to maximize the benefits of rehabilitation for improved function in persons with stroke, Parkinson’s and other neurological disorders.

BOARD OF DIRECTORS

DAVID PERRYMAN

DAVID PERRYMAN

Chairman

Read More

David Perryman, J.D., is Chief Operating Officer of Drug Innovation Ventures at Emory University (DRIVE) in Atlanta.  He was formerly President, CEO and a founder of Zirus. David has played many roles in his 25 years in the biotechnology industry. In addition to Zirus, David has founded two other biotechnology companies: one was acquired and the second became a publicly traded company. David has served on the Board of Directors of these and other biotechnology companies.

Prior to joining Zirus, he was a shareholder and head of the Biotechnology Patent Practice group at Needle & Rosenberg, an IP boutique law firm. He practiced biotechnology patent law for 20 years delivering patent business strategy to biotech companies, venture capital funds, the CDC, NIH, FDA and numerous universities. He also served as a founder and special advisor to Georgia Venture Partners, a state associated biotech venture capital fund.

David served as a panelist at the Institute of Medicine’s Countermesure/Bioterrorism policy meeting (2010) as well as a featured presenter in Developments in Biodefense and Technology Platforms at the 8th Annual BioDefense Summit 2010. He received the 2014 Industry Growth Award from GaBio, considered the top award in Georgia for contribution to the state’s biotechnology industry.

DAVID HUIZENGA

DAVID HUIZENGA

Founder and CEO

Read More

David E. Huizenga is the founder and CEO of Moterum Technologies Inc., a medical device company in stroke rehabilitation. He is an expert in translating groundbreaking science into realistic commercial opportunities. Over the last 5 years, he has focused his efforts on the unique needs of the neural rehabilitation patient. Previously, David was CEO and cofounder of Tao Life Sciences LLC, an early stage life sciences technology development and investment company, which successfully monetized over half of its portfolio. David has been on the founding team of numerous life science companies, and has involvement in successful acquisitions and exits. Mr. Huizenga obtained his Ph.D. from Harvard, in the laboratory of Jack Szostak, Nobel Laureate in Medicine, and his Law Degree from Emory University Law School, where he was a Woodruff Fellow. Mr. Huizenga serves on numerous corporate and non-profit boards.
MANOJ AGARWALA

MANOJ AGARWALA

President

Read More

Manoj Agarwala is a serial entrepreneur. He successfully started and grew two technology companies – hCentive and GlobalLogic which grew to over 5,000 employees and expanded to over 6 countries. He was President and Chief Operating Officer for hCentive from 2009 to 2016. At hCentive Manoj oversaw the company’s Operations, Finance, Legal, R&D, Professional Services and Marketing.
COOPER COLLINS

COOPER COLLINS

Read More

Mr. Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an Advisor to a number of pharmaceutical and biotechnology companies. Mr. Collins is the Founder and Advisor of Pernix Therapeutics Holdings, Inc. He served as the Chief Strategic Officer of Pernix Therapeutics Holdings, Inc. from May 2013 to April 15, 2014 and also served as its President from January 2007 to May 2013 and Chief Executive Officer from June 2008 to May 2013.

He served as the President and Chief Executive Officer of Pernix Therapeutics, LLC. From December 2005 to December 2007, he served as Vice President of Business and Product Development at Pernix and from December 2003 to December 2005, he served as Pernix’s Territory Manager. He was responsible for acquiring companies and products, attracting investors and increasing the overall efficiency. He served at the NFL franchise The New Orleans Saints in their media relations department for three years. He has been a Director of Oncternal Therapeutics, Inc. since February 22, 2017.

He has been an Independent Director of TherapeuticsMD, Inc. since February 28, 2012. He serves as a Director of Pernix Sleep, Inc. and Anthem Vault Inc. He served as a Director of Pernix Therapeutics Holdings, Inc. from January 1, 2007 to February 2014. Mr. Collins earned a BA and an MBA from Nicholls State University in Thibodaux, Louisiana.

KARAN SORENSEN

KARAN SORENSEN

Read More

Karan Sorensen is an expert in digital health, information technologies, and the “internet of things”. Through her previous roles as a CIO and head of Digital Health for companies, such as Johnson & Johnson Pharmaceutical Research & Development LLC and Life Technologies, she pioneered global programs in the digital health arenas, such as Johnson and Johnson’s Total Oncology Digital Health Program.

Her excellence in the digital health world has garnered numerous awards including, Bio-IT World Best Practices, CIO magazine and CIO.COM awards including the CIO 100 award and CIO 100+ Competitive Advantage award. She has special expertise in executing innovation, information and technology solutions, building businesses, implementing operational excellence programs and developing leaders. Karan has been called a visionary and inspirational leader adept at shaping technical and business strategies, creating an energetic climate for growth and excellence, delivering large-scale goals, and motivating others to achieve their highest levels of growth and performance.

She has a reputation for excellence in creating high performance global teams and organizations and for administering multi-million dollar budgets. A technopreneur, Karan serves as a board member and advisor for technology start-ups, colleges, universities and industry standards organizations.

DAN ADAMS

DAN ADAMS

Read More

Dan Adams is Co-Founder and Executive Chairman of NextWaveBio, a new company that is developing the next generation of safer, more affordable medicines. Previously he was CEO and then Executive Chairman of Protein Sciences Corporation, a leader in developing vaccines using its proprietary baculovirus expression vector (BEST) system. The US FDA licensed its lead vaccine, Flublok®, the first recombinant influenza vaccine, in January 2013, extended the age range in 2014 and approved the quadrivalent formulation in 2018. Flublok was also licensed in Mexico in 2016. The Company had a value of less than $2 million in 1996 and in 2017 it was acquired by Sanofi Pasteur for about $750 million. Previously Dan founded and managed several biotechnology companies that achieved a combined value of in excess of $70 billion. He co-founded Biogen in 1976 and was its first CEO; founded and was CEO of Advanced Genetic Sciences Inc., the first plant biotechnology company (Biogen and AGS were taken public in the 1980s), founded Plant Genetic Systems, the first European agricultural biotechnology company, and served as a managing director and chairman of the management committee (PGS was acquired by Agrivo for $750 million) and founded and was CEO of Allerx Inc. in 1999 – now a boutique company.

Would you like to receive free updates about the Moterum iStride Solution™, and other breaking developments in stroke gait rehabilitation?